Pharma Focus Asia

Pistoia Alliance Partners with Matador

Thursday, June 15, 2023

The Pistoia Alliance has recently announced a partnership with Matador to facilitate collaborative efforts in the Japanese market, focusing on pre-competitive collaboration. 

This strategic collaboration aims to enhance the adoption of new technologies and leverage Japan's research and development expertise in key areas such as targeted immunotherapy, the human microbiome, and neurology. Moreover, it aims to promote advancements in pharmaceutical research and development and drive progress in the field.

By combining forces, the Pistoia Alliance and Matador aims to leverage combined resources and expertise to support member organisations in accelerating their research efforts and provide access to a comprehensive global pharmaceutical ecosystem. 

The partnership between the Pistoia Alliance and Matador aims to establish networking and interest groups that cater specifically to the Japanese market. These groups will operate in the local language and time zone, which will directly benefit member organisations in the region. 

Partnering with the Pistoia Alliance will grant members access to global expertise in these domains, further enhancing their capabilities and opportunities for collaboration.

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024